Summary
Vascular dementias (VaDs) are the second most common cause of dementia. Cerebrovascular disease (CVD) and stroke relates to high risk of cognitive impairment, but also relate to Alzheimer’s disease (AD):
Vascular cognitive impairment (VCI) and dementias extend beyond the traditional multi-infarct dementia. Pathophysiology of VaD incorporates interactions between vascular etiologies (CVD and vascular risk-factors), changes in the brain (infarcts, white matter lesions, atrophy), host factors (age, education) and cognition.
Variation in defining the cognitive syndrome, in vascular etiologies, and allowable brain changes in current criteria have resulted in variable estimates of prevalence, of groups of subjects, and of the types and distribution of putative causal brain lesions.
Should new criteria be developed? Ideally in constructing new criteria the diagnostic elements should be tested with prospective studies with clinical-pathological correlation: replace dogma with data. Meanwhile focus on more homogenous subtypes of VaD, and on imaging criteria could be a solution.
Subcortical ischemic vascular disease and dementia (SIVD) incorporate small vessel disease as the chief vascular etiology, lacunar infarct and ischaemic white matter lesions as primary type of brain lesions, subcortical location as the primary location of lesions, and subcortical syndrome as the primary clinical manifestation. It incorporates two clinical entities “Binswanger’s disease” and “the lacunar state”.
AD with VaD (mixed dementia) has been underestimated as a prevalent cause in the older population. In addition to simple co-existence, VaD and AD have closer interaction: several vascular risk factors and vascular brain changes relate to clinical manifestation of AD, and they share also common pathogenetic mechanisms.
Vascular cognitive impairment (VCI) is a category aiming to replace the “Alzhemerized” dementia concept in the setting of CVD, and substitute it with a spectrum that includes subtle cognitive deficits of vascular origin, poststroke dementia, and the complex group of the vascular dementias.
As far there is no standard treatment for VaDs, and still little is known on the primary prevention (brain at risk for CVD) and secondary prevention (CVD brain at risk for VCI/VaD). There is no standard symptomatic treatment for VaD. Recently symptomatic cholinergic treatment has shown promise in AD with VaD, as well as probable VaD. Future focus should be directed to the distinct etiological and pathological factors: the vascular and the AD burden of the brain.
A review based on a lecture given in the European Institute of Healthcare — CNS Symposium, December 1, 2001, Barcelona, Spain
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amar K, Wilcock G (1996) Vascular dementia [Review] [65 refs]. BMJ 312: 227–231
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th ed. American Psychiatric Association, Washington, DC
Babikian V, Ropper AH (1987) Binswanger’s disease: a review. Stroke 18: 2–12
Berchtold NC, Cotman CW (1998) Evolution in the conceptualization of dementia and Alzheimer’s disease: Greco Roman period to the 1960s. Neurobiol Aging 19: 173–189
Bowler JV, Hachinski V (1995) Vascular cognitive impairment: a new approach to vascular dementia. [Review] [75 refs]. Baillieres Clin Neurol 4: 357–376
Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82: 239–259
Brun A (1994) Pathology and pathophysiology of cerebrovascular dementia: pure subgroups of obstructive and hypoperfusive etiology. Dementia 5: 145–147
Brust JC (1988) Vascular dementia is overdiagnosed [Review] [76 refs]. Arch Neurol 45: 799–801
Chui HC (1989) Dementia: a review emphasizing clinicopathologic correlation nd brainbehavior relationships. Arch Neurol 46: 806–814
Chui HC (1998) Rethinking vascular dementia: moving from myth to mechanism. In: Growdon JH, Rossor MN (eds) The dementias. Butterworth-Heinemann, Boston, pp 377–401
Chui HC (2001) Vascular dementia, a new beginning. Shifting focus from clinical phenotype to ischemic brain injury. Neuroloci clinics 18: 951–977
Chui HC, Gonthier R (1999) Natural history of vascular dementia. Alzheimer Dis Assoc Disord
Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R (1992) Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers [see comments]. Neurology 42: 473–480
Cummings JL (1993) Fronto-subcortical circuits and human behavior. Arch Neurol 50: 873–880
Cummings JL (1994) Vascular subcortical dementias: clinical aspects [Review] [25 refs]. Dementia 5:177–180
Desmond DW (1996) Vascular dementia: a construct in evolution [Review] [215 refs]. Cerebrovasc Brain Metab Rev 8: 296–325
Desmond DW, Erkinjuntti T, Sano M et al (1999) The cognitive syndrome of vascular dementia: implications for clinical trials. Alzheimer Dis Assoc Disord
Doody RS, Stevens JC, Beck C et al (2001) Practice parameter: Management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56: 1154–1166
Erkinjuntti T (1987a) Differential diagnosis between Alzheimer’s disease and ascular dementia: evaluation of common clinical methods. Acta Neurol Scand 76: 433–442
Erkinjuntti T (1987b) Types of multi-infarct dementia. Acta Neurol Scand 75: 391–399
Erkinjuntti T (1994) Clinical criteria for vascular dementia: the NINDS-AIREN criteria. Dementia 5: 189–192
Erkinjuntti T (1996) Clinicopathological study of vascular dementia. In: Prohovnik I, Wade J, Knezevic S, Tatemichi TK, Erkinjuntii T (eds) Vascular dementia. Current concepts. John Wiley & Sons, Chichester, pp 73–112
Erkinjuntti T (1997) Vascular dementia: challenge of clinical diagnosis. Int Psychogeriatr 9: 51–58
Erkinjunti T (1999) Cerebrovascular dementia: a quide to diagnosis and treatment. CNS Drugs
Erkinjuntti T, Hachinski VC (1993) Rethinking vascular dementia. Cerebrovasc Dis 3: 3–23
Erkinjuntti T, Pantoni L (2002) Subcortical vascular dementia. In: Gauthier S, Cummings JL (eds) Alzheimer’s diasease and related disorders annual. Martin Dunitz, London, pp 101–133
Erkinjuntti T, Haltia M, Palo J, Sulkava R, Paetau A (1988) Accuracy of the clinical diagnosis of vascular dementia: a rospective clinical and post-mortem neuropathological study. J Neurol Neurosurg Psychiatry 51: 1037–1044
Erkinjuntti T, Benavente O, Eliasziw M et al (1996) Diffuse vacuolization (spongiosis) and arteriolosclerosis in the frontal white matter occurs in vascular dementia. Arch Neurol 53: 325–332
Erkinjuntti T, Ostbye T, Steenhuis R, Hachinski V (1997a) The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med 337: 1667–1674
Erkinjuntti T, Ostbye T, Steenhuis R, Hachinski V (1997b) The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med 337: 1667–1674
Erkinjuntti T, Bowler JV, DeCarli C et al (1999) Imaging of static brain lesions in vascular dementia: implications for clinical trials. Alzheimer Dis Assoc Disord 13: S81–S90
Erkinjuntti T, Inzitari D, Pantoni L et al (2000) Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm 59: 23–30
Erkinjunti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, ChandrasekharRao VD (2001) Galantamine is efficacious in probable vascular dementia and Alzheimer’s disease combined with cerebrovascular disease. J Am Ger Soc (in press)
Fischer P, Gatterer G, Marterer A, Simanyi M, Danielczyk W (1990) Course characteristics in the differentiation of dementia of the Alzheimer type and multi-infarct dementia. Acta Psychiatr Scand 81: 551–553
Fratiglioni L, Launer LJ, Andersen K et al (2000) Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 54: S10–S15
Gold G, Giannakopoulos P, Montes-Paixao JC et al (1997) Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia. Neurology 49: 690–694
Gortelmeyer R, Erbler H (1992) Memantine in treatment of mild to moderate dementia syndrome. Drug Res 42: 904–912
Hachinski VC (1990) The decline and resurgence of vascular dementia [Review] [41 refs]. CMAJ 142:107–111
Hachinski V (1992) Preventable senility: a call for action against the vascular dementias [see comments] [Review] [33 refs]. J Am Ger Soc 340: 645–648
Hachinski VC, Lassen NA, Marshall J (1974) Multi-infarct dementia. A cause of mental deterioration in he elderly. J Am Ger Soc ii: 207–210
Hachinski VC, Iliff LD, Zilhka E et al (1975) Cerebral blood flow in dementia. Arch Neurol 32: 632–637
Hebert R, Brayne C (1995) Epidemiology of vascular dementia [Review] [75 refs]. Neuroepidemiology 14: 240–257
Inzitari D, Erkinjuntti T, Wallin A, del Ser T, Romanelli M, Pantoni L (2000) Subcortical vascular dementia as a specific target for clinical trials. Ann NY Acad Sci 903: 510–521
Ishii N, Nishihara Y, Imamura T (1986) Why do frontal lobe symptoms predominate in vascular dementia with lacunes? Neurology 36: 340–345
Kalaria RN, Ballard C (1999) Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord 13: S115–S123
Knezevic S, Labs KH, Kittner B, Rossner M, Rother M (1996) The treatment of vascular dementia: problems and prospects. In: Prohovnik I, Wade J, Knesevich J, Tatemichi TK, Erkinjunti T (eds) Vascular dementia. Current concepts. John Wiley & Sons, Chichester, pp 301–312
Kokmen E, Whisnant JP, O’Fallon WN, Chu CP, Beard CM (1996) Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960–1984). Neurology 46: 154–159
Konno S, Meyer JS, Terayama Y, Margishvili GM, Mortel KF (1997) Classification, diagnosis and treatment of vascular dementia [Review] [83 refs]. Drugs & Aging 11:361–373
Last JM (1988) A dictionary of epidemiology, 2nd edn. Oxford University Press, New York
Lechner H (1998) Status of treatment of vascular dementia [Review] [19 refs]. Neuroepidemiology 17: 10–13
Lobo A, Launer LJ, Fratiglioni L et al (2000) Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 54: S4–S9
Loeb C, Meyer JS (1996) Vascular dementia: still a debatable entity? [Review] [50 refs]. J Neurol Sci 143: 31–40
Loeb C, Gandolfo C, Croce R, Conti M (1992) Dementia associated with lacunar infarction. Stroke 23: 1225–1229
Lopez OL, Larumbe MR, Becker JT et al (1994) Reliability of NINDS-AIREN clinical criteria for the diagnosis of vascular dementia [see comments]. Neurology 44: 1240–1245
Mahler ME, Cummings JL (1991) The behavioural neurology of multi-infarct dementia. Alzheimer Dis Assoc Disord 5:122–130
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34: 939–944
Meyer JS, Judd BW, Tawaklna T, Rogers RL, Mortel KF (1986) Improved cognition after control of risk factors for multi-infarct dementia. JAMA 256: 2203–2209
Meyer JS, Rogers RL, McClintic K, Mortel KF, Lotfi J (1989) Randomized clinical trial of daily aspirin therapy in multi-infarct dementia. A pilot study. J Am Geriatr Soc 37: 549–555
Mielke R, Herholz K, Grond M, Kessler J, Heiss WD (1992) Severity of vascular dementia is related to volume of metabolically impaired tissue. Arch Neurol 49: 909–913
Moroney JT, Bagiella E, Desmond DW, Paik MC, Stern Y, Tatemichi TK (1996) Risk factors for incident dementia after stroke. Role of hypoxic and ischemic disorders. Stroke 27:1283–1289
Moroney JT, Bagiella E, Desmond DW et al (1997) Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurology 49:1096–1105
Mortel KF, Meyer JS (1995) Lack of postmenopausal estrogen replacement therapy and the risk of dementia. J Neuropsychiatr Clin Neurosci 7: 334–337
Molsa PK, Marttila RJ, Rinne UK (1995) Long-term survival and predictors of mortality in Alzheimer’s disease and multi-infarct dementia. Acta Neurol Scand 91: 159–164
Pantoni L, Garcia JH (1995) The significance of cerebral white matter abnormalities 100 years after Binswanger’s report. A review [Review] [164 refs]. Stroke 26:1293–1301
Pantoni L, Lammie A (2002) Cerebral small vessel disease: pathological and pathophysiological aspects in relation to vascular cognitive impairment. In: Erkinjunti T, Gauthier S (eds) Vascular cognitive impairment. Martin Dunitz, London
Pantoni L, Carosi M, Amigoni S, Mascalchi M, Inzitari D (1996) A preliminary open trial with nimodipine in patients with cognitive impairment and leukoaraiosis. Clin Neuropharmacol 19: 497–506
Pasquier F, Leys D (1997) Why are stroke patients prone to develop dementia? [Review] [94 refs]. J Neurol 244:135–142
Petersen RC (1995) Normal aging, mild cognitive impairment, and early Alzheimer’s disease. The Neurologist 1: 326–344
Pohjasvaara T, Erkinjuntti T, Vataja R, Kaste M (1997) Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke 28: 785–792
Rocca WA, Hofman A, Brayne C et al (1991) The prevalence of vascular dementia in Europe: facts and fragments from 1980–1990 studies. EURODEM-Prevalence Research Group. Ann Neurol 30: 817–824
Rockwood K, Parhad I, Hachinski V et al (1994) Diagnosis of vascular dementia: Consortium of Canadian Centres for Clinical Cognitive Research concensus statement [Review] [60 refs]. Can J Neurol Sci 21: 358–364
Rockwood K, Bowler J, Erkinjunti T, Hachinski V, Wallin A (1999) Subtypes of vascular dementia. Alzheimer Dis Assoc Disord 13: S59–S64
Roman GC (1987) Senile dementia of the Binswanger type. A vascular form of dementia in the elderly. JAMA 258:1782–1788
Roman GC, Tatemichi TK, Erkinjuntti T et al (1993) Vascular dementia: diagnostic criteria for reserach studies. Report of the NINDS-AIREN International Work Group. Neurology 43: 250–260
Rother M, Erkinjuntti T, Roessner M, Kittner B, Marcusson J, Karlsson I (1998) Propentofylline in the treatment of Alzheimer’s disease and vascular dementia. Dementia Geriatr Cogn Disord 9: 36–43
Skoog I (1997) Blood pressure and dementia. In: Hansson L, Birkenhager WH (eds) Handbook of hypertension, vol 18. Assessment of hypertensive organ damage. Elsevier Science BV, Amsterdam, pp 303–331
Skoog I (1997b) The relationship between blood pressure and dementia: a review [Review] [139 refs]. Biomed Pharmacother 51: 367–375
Skoog I (1998) Status of risk factors for vascular dementia [Review] [89 refs]. Neuroepidemiology 17: 2–9
Skoog I, Nilsson L, Palmertz B, Andreasson L-A, Svanborg A (1993) A population-based study on dementia in 85-year-olds. N Engl J Med 328:153–158
Skoog I, Kalaria RN, Breteler MMB (1999) Vascular factors and Alzheimer’s disease. Alzheimer Dis Assoc Disord 13: S106–S114
Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR (1997) Brain infarction and the clinical expression of Alzheimer disease. The Nun Study [see comments]. JAMA 277: 813–817
Sulkava R, Erkinjuntti T (1987) Vascular dementia due to cardiac arrhythmias and systemic ypotension. Acta Neurol Scand 76:123–128
Suzuki K, Kutsuzawa T, Nakajima K, Hatano S (1991) Epidemiology of vascular dementia and stroke in Akita, Japan. In: Hartmann A, Kuchinsky W, Hoyer S (eds) Cerebral ischemia and dementia. Springer, New York, pp 16–24
Tatemichi TK (1990) How acute brain failure becomes chronic. A view of the echanisms and syndromes of dementia related to stroke. Neurology 40: 1652–1659
Tatemichi TK, Desmond DW, Mayeux R et al (1992) Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 42: 1185–1193
Tatemichi TK, Paik M, Bagiella E, Desmond DW, Pirro M, Hanzawa LK (1994) Dementia after stroke is a predictor of long-term survival. Stroke 25: 1915–1919
Tatemichi TK, Paik M, Bagiella E et al (1994) Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology 44:1885–1891
Tomlinson BE, Blessed G, Roth M (1970) Observations on the brains of demented old people. J Neurol Sci 11: 205–242
Verhey FR, Lodder J, Rozendaal N, Jolles J (1996) Comparison of seven sets of criteria used for the diagnosis of vascular dementia. Neuroepidemiology 15:166–172
Wallin A, Blennow K (1994) The clinical diagnosis of vascular dementia [Review] [11 refs]. Dementia 5:181–184
Wetterling T, Kanitz RD, Borgis KJ (1994) The ICD-10 criteria for vascular dementia. Dementia 5: 185–188
Wetterling T, Kanitz RD, Borgis KJ (1996) Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). Stroke 27: 30–36
World Health Organization (1993) ICD-10 Classification of mental and behavioural disorders: diagnostic criteria for research. WHO, Geneva
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Wien
About this paper
Cite this paper
Erkinjuntti, T. (2002). Diagnosis and management of vascular cognitive impairment and dementia. In: Fleischhacker, W.W., Brooks, D.J. (eds) Stroke-Vascular Diseases. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6137-1_6
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6137-1_6
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83866-2
Online ISBN: 978-3-7091-6137-1
eBook Packages: Springer Book Archive